Hepatitis B virus(3) Novel coronavirus(2) entecavir(2) COVID‐19(2) Taiwan(2) SARS‐CoV‐2(2) lamivudine(2) infection control(2) FIB4-AA(1) retreatment decision(1) Disease burden(1) stress.(1) primary culture(1) TGF-β1(1) Tumor necrosis factor α.(1) FIB-4(1) Relapse(1) host-dominating flare(1) telbivudine.(1) Hepatocellular carcinoma(1) FOXP3(1) Lymphotoxin α(1) Injecting drug users(1) age-adjusted(1) Switch.(1) stopping rule(1) outcome(1) 2019 novel coronavirus (SARS-CoV-2)(1) CRP(1) Single nucleotide polymorphism(1)